open access

Vol 66, No 1 (2016)
Oncological debates
Published online: 2016-04-07
Get Citation

Option for continuation of chemotherapy until disease progression in advanced breast cancer patients

Renata Duchnowska
DOI: 10.5603/NJO.2016.0007
·
Nowotwory. Journal of Oncology 2016;66(1):61-63.

open access

Vol 66, No 1 (2016)
Oncological debates
Published online: 2016-04-07

Abstract

The maintenance chemotherapy in patients with advanced breast cancer is still a matter of controversy. A meta-analysis of 11 randomised trials including phenotypically and therapeutically heterogeneous groups of patients, showed that maintenance chemotherapy prolongs time to progression and survival, and does not affect (but sometimes actually improves) quality of life. However, the decision on treatment duration should take into account the type of chemotherapy, its tolerability and effect, as well as the informed preference of the patient.

Abstract

The maintenance chemotherapy in patients with advanced breast cancer is still a matter of controversy. A meta-analysis of 11 randomised trials including phenotypically and therapeutically heterogeneous groups of patients, showed that maintenance chemotherapy prolongs time to progression and survival, and does not affect (but sometimes actually improves) quality of life. However, the decision on treatment duration should take into account the type of chemotherapy, its tolerability and effect, as well as the informed preference of the patient.

Get Citation
About this article
Title

Option for continuation of chemotherapy until disease progression in advanced breast cancer patients

Journal

Nowotwory. Journal of Oncology

Issue

Vol 66, No 1 (2016)

Pages

61-63

Published online

2016-04-07

DOI

10.5603/NJO.2016.0007

Bibliographic record

Nowotwory. Journal of Oncology 2016;66(1):61-63.

Authors

Renata Duchnowska

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media sp. z o.o. VM Group sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl